Informational needs assessment of non-Hodgkin lymphoma survivors and their physicians

被引:20
|
作者
Friedman, Daphne R. [1 ]
Coan, April D. [2 ]
Smith, Sophia K. [2 ,3 ]
Herndon, James E., II [2 ,4 ]
Abernethy, Amy P. [1 ,2 ]
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27705 USA
[2] Duke Univ, Med Ctr, Duke Comprehens Canc Ctr, Durham, NC 27710 USA
[3] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA
[4] Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27705 USA
关键词
CANCER SURVIVORS; CARE;
D O I
10.1002/ajh.21725
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cancer Survivorship Care Plans (SCPs) are a recommended part of medical care for cancer survivors. We sought to identify the medical and psychosocial informational needs of non-Hodgkin lymphoma survivors and their physicians in cancer survivorship care to be included in SCPs. Questionnaires were mailed to eligible lymphoma survivors and their physicians, querying their preferences about informational needs in SCPs. The survivor cohort had a median age at diagnosis of 62, with 57% Female, 87% White, and 76% from North Carolina. The physician cohort was comprised of oncologists (27%) and nononcologists (73%), and 86% practiced in North Carolina. Greater than 60% of both survivors and physicians preferred an oncologist and primary care provider comanage cancer survivorship care. The most highly rated informational needs were medical issues, although there were differences between survivors and physicians for many of the informational needs queried. There was higher concordance between patient and physician responses for medical issues (63 to 100%) compared to psychosocial issues (25 to 63%). Important components of SCPs for lymphoma survivors and their physicians may go unrecognized. Tailoring SCPs to patient or physician users may better accommodate the differences in need for particular cancer survivorship care information.
引用
收藏
页码:528 / 532
页数:5
相关论文
共 50 条
  • [31] NON-HODGKIN LYMPHOMA OF THE LUNGS
    BALIKIAN, JP
    HERMAN, PG
    RADIOLOGY, 1979, 132 (03) : 569 - 576
  • [32] Non-Hodgkin Lymphoma Metabolism
    Kirsch, Brian James
    Chang, Shu-Jyuan
    Betenbaugh, Michael James
    Le, Anne
    HETEROGENEITY OF CANCER METABOLISM, 2ND EDITION, 2021, 1311 : 103 - 116
  • [33] HCV and non-Hodgkin lymphoma
    Pioltelli, P
    Zehender, G
    Monti, G
    Monteverde, A
    Galli, M
    LANCET, 1996, 347 (9001): : 624 - 625
  • [34] Non-Hodgkin's lymphoma
    Smith, MR
    CURRENT PROBLEMS IN CANCER, 1996, 20 (01) : 6 - 77
  • [35] Radioimmunotherapy in non-Hodgkin lymphoma
    Chanan-Khan, A
    Czuczman, MS
    CURRENT OPINION IN ONCOLOGY, 2002, 14 (05) : 484 - 489
  • [36] INTRANEURAL NON-HODGKIN LYMPHOMA
    DEREVEL, T
    CASASNOVAS, O
    PARRAF, F
    GEROSA, Y
    SCHILL, H
    DUCHATELARD, PP
    PRESSE MEDICALE, 1990, 19 (10): : 472 - 472
  • [37] Non-Hodgkin lymphoma of the prostate
    Steuter, John
    Weisenburger, Dennis D.
    Bociek, R. Greg
    Bierman, Philip
    Vose, Julie
    Bast, Martin
    Loberiza, Fausto
    Armitage, James O.
    AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (11) : 952 - 954
  • [38] NON-HODGKIN LYMPHOMA OF THE TESTIS
    TEPPERMAN, BS
    GOSPODAROWICZ, MK
    BUSH, RS
    BROWN, TC
    RADIOLOGY, 1982, 142 (01) : 203 - 208
  • [39] Non-Hodgkin's lymphoma
    Rule, SAJ
    CLINICAL MEDICINE, 2001, 1 (05) : 362 - 364
  • [40] NON-HODGKIN LYMPHOMA OF BONE
    BRAUNSTEIN, EM
    WHITE, SJ
    RADIOLOGY, 1980, 135 (01) : 59 - 63